Integer (NYSE:ITGR) Price Target Raised to $145.00

Integer (NYSE:ITGR) had its price target hoisted by Truist Financial from $137.00 to $145.00 in a report published on Tuesday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

Several other research firms also recently commented on ITGR. Benchmark reiterated a buy rating and issued a $130.00 price target on shares of Integer in a research report on Friday, August 2nd. Oppenheimer started coverage on shares of Integer in a research report on Tuesday, July 16th. They issued an outperform rating and a $135.00 price target for the company. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus target price of $137.29.

Integer Trading Up 2.6 %

NYSE ITGR opened at $129.11 on Tuesday. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. Integer has a 52 week low of $69.40 and a 52 week high of $131.87. The stock has a market capitalization of $4.33 billion, a PE ratio of 44.67, a price-to-earnings-growth ratio of 1.87 and a beta of 1.08. The firm has a 50 day moving average of $123.88 and a two-hundred day moving average of $119.52.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $436.20 million during the quarter, compared to analysts’ expectations of $437.00 million. During the same quarter in the prior year, the business posted $1.14 EPS. The company’s revenue for the quarter was up 9.0% on a year-over-year basis. As a group, research analysts expect that Integer will post 5.31 EPS for the current fiscal year.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares of the company’s stock, valued at $272,824.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integer

A number of institutional investors and hedge funds have recently made changes to their positions in ITGR. Quest Partners LLC grew its stake in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 332 shares during the last quarter. GAMMA Investing LLC grew its stake in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Integer in the 1st quarter valued at about $106,000. Innealta Capital LLC acquired a new stake in Integer in the 2nd quarter valued at about $110,000. Finally, Hancock Whitney Corp acquired a new stake in Integer in the 1st quarter valued at about $203,000. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.